APA

Pollard R. P. E., Abdulahad W. H., Vissink A., Hamza N., Burgerhof J. G. M., Meijer J. M., Visser A., Huitema M. G., Spijkervet F. K. L., Kallenberg C. G. M., Bootsma H. & Kroese F. G. M. (20130306). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. : Annals of the rheumatic diseases.

Chicago

Pollard Rodney P E, Abdulahad Wayel H, Vissink Arjan, Hamza Nishath, Burgerhof Johannes G M, Meijer Jiska M, Visser Annie, Huitema Minke G, Spijkervet Fred K L, Kallenberg Cees G M, Bootsma Hendrika and Kroese Frans G M. 20130306. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. : Annals of the rheumatic diseases.

Harvard

Pollard R. P. E., Abdulahad W. H., Vissink A., Hamza N., Burgerhof J. G. M., Meijer J. M., Visser A., Huitema M. G., Spijkervet F. K. L., Kallenberg C. G. M., Bootsma H. and Kroese F. G. M. (20130306). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. : Annals of the rheumatic diseases.

MLA

Pollard Rodney P E, Abdulahad Wayel H, Vissink Arjan, Hamza Nishath, Burgerhof Johannes G M, Meijer Jiska M, Visser Annie, Huitema Minke G, Spijkervet Fred K L, Kallenberg Cees G M, Bootsma Hendrika and Kroese Frans G M. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. : Annals of the rheumatic diseases. 20130306.